Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease.


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
31 Oct 2024
Historique:
received: 16 01 2024
accepted: 30 09 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production ([Formula: see text] We hypothesized that the [Formula: see text] Compared with the GOLD I-II group (n = 51), peak [Formula: see text] The OUES may be less useful in advanced COPD with exertional hypoxemia. The [Formula: see text]

Sections du résumé

BACKGROUND BACKGROUND
In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production ([Formula: see text]
METHODS METHODS
We hypothesized that the [Formula: see text]
RESULTS RESULTS
Compared with the GOLD I-II group (n = 51), peak [Formula: see text]
CONCLUSIONS CONCLUSIONS
The OUES may be less useful in advanced COPD with exertional hypoxemia. The [Formula: see text]

Identifiants

pubmed: 39482616
doi: 10.1186/s12890-024-03312-2
pii: 10.1186/s12890-024-03312-2
doi:

Substances chimiques

Carbon Dioxide 142M471B3J
Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

550

Subventions

Organisme : A Grant-in-Aid for Clinical Research from the National Hospital Organization
ID : Not applicable

Informations de copyright

© 2024. The Author(s).

Références

Armstrong M, Vogiatzis I. Personalized exercise training in chronic lung diseases. Respirology. 2019;24(9):854–62.
doi: 10.1111/resp.13639 pubmed: 31270909
Riley CM, Sciurba FC. Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: a review. JAMA. 2019;321(8):786–97.
doi: 10.1001/jama.2019.0131 pubmed: 30806700
Sepúlveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis, prevalence, and clinical impact of Sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11(5):1164–76.
doi: 10.1002/jcsm.12600 pubmed: 32862514 pmcid: 7567149
Wasserman K, Hansen J, Sue D, Stringer W, Sietsema K, Sun X-G. Principles of exercise testing and interpretation: including pathophysiology and clinical applications. Philadelphia: Lippincott Williams and Wilkins; 2012.
Laviolette L, Laveneziana P. Exercise Testing in the prognostic evaluation of patients with lung and heart diseases. In: Clinical Exercise Testing (ERS Monograph). edn. Edited by Palange P, Laveneziana P, Neder JA, Ward SA. Sheffield: European Respiratory Society; 2018: 222–234.
Ward SA. Determinants of the physiological systems’ response to muscular exercise in healthy subjects. In: Clinical Exercise Testing (ERS Monograph). edn. Edited by Palange P, Laveneziana P, Neder JA, Ward SA. Sheffield: European Respiratory Society; 2018: 1–33.
Neder JA, Berton DC, Arbex FF, Alencar MC, Rocha A, Sperandio PA et al. Physiological and clinical relevance of exercise ventilatory efficiency in COPD. Eur Respir J 2017, 49(3).
Weatherald J, Sattler C, Garcia G, Laveneziana P. Ventilatory response to exercise in cardiopulmonary disease: the role of chemosensitivity and dead space. Eur Respir J 2018, 51(2).
Miki K, Tsujino K, Maekura R, Matsuki T, Miki M, Hashimoto H, et al. Oxygen extraction based on Inspiratory and Expiratory Gas Analysis identifies Ventilatory Inefficiency in Chronic Obstructive Pulmonary Disease. Front Physiol. 2021;12:703977.
doi: 10.3389/fphys.2021.703977 pubmed: 34393822 pmcid: 8355815
Miyazaki A, Miki K, Maekura R, Tsujino K, Hashimoto H, Miki M et al. Increased oxygen extraction by Pulmonary Rehabilitation improves Exercise Tolerance and Ventilatory Efficiency in Advanced Chronic Obstructive Pulmonary Disease. J Clin Med 2022, 11(4).
Sun XG, Hansen JE, Stringer WW. Oxygen uptake efficiency plateau best predicts early death in heart failure. Chest. 2012;141(5):1284–94.
doi: 10.1378/chest.11-1270 pubmed: 22030802
Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, et al. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996;28(6):1567–72.
doi: 10.1016/S0735-1097(96)00412-3 pubmed: 8917273
Baba R, Kubo N, Morotome Y, Iwagaki S. Reproducibility of the oxygen uptake efficiency slope in normal healthy subjects. J Sports Med Phys Fit. 1999;39(3):202–6.
Davies LC, Wensel R, Georgiadou P, Cicoira M, Coats AJ, Piepoli MF, et al. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J. 2006;27(6):684–90.
doi: 10.1093/eurheartj/ehi672 pubmed: 16338939
American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–36.
doi: 10.1164/ajrccm.152.3.7663792
Radtke T, Crook S, Kaltsakas G, Louvaris Z, Berton D, Urquhart DS et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev 2019, 28(154).
Barron A, Francis DP, Mayet J, Ewert R, Obst A, Mason M, et al. Oxygen Uptake Efficiency Slope and Breathing Reserve, not anaerobic threshold, discriminate between patients with Cardiovascular Disease over Chronic Obstructive Pulmonary Disease. JACC Heart Fail. 2016;4(4):252–61.
doi: 10.1016/j.jchf.2015.11.003 pubmed: 26874378 pmcid: 4820007
Kagawa H, Miki K, Kitada S, Miki M, Yoshimura K, Oshitani Y, et al. Dyspnea and the varying pathophysiologic manifestations of Chronic Obstructive Pulmonary Disease evaluated by Cardiopulmonary Exercise Testing with arterial blood analysis. Front Physiol. 2018;9:1293.
doi: 10.3389/fphys.2018.01293 pubmed: 30333757 pmcid: 6176099
O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA. Dyspnea in COPD: new mechanistic insights and management implications. Adv Ther. 2020;37(1):41–60.
doi: 10.1007/s12325-019-01128-9 pubmed: 31673990
Miki K, Tsujino K, Fukui M, Miki M, Kitajima T, Sumitani H, et al. Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial. Thorax. 2023;79(1):23–34.
doi: 10.1136/thorax-2022-219755 pubmed: 37696622
Phillips DB, Collins S, Stickland MK. Measurement and interpretation of Exercise Ventilatory Efficiency. Front Physiol. 2020;11:659.
doi: 10.3389/fphys.2020.00659 pubmed: 32714201 pmcid: 7344219
Mezzani A, Giordano A, Komici K, Corrà U. Different determinants of ventilatory inefficiency at different stages of reduced ejection Fraction Chronic Heart failure natural history. J Am Heart Assoc 2017, 6(5).
Nayor M, Xanthakis V, Tanguay M, Blodgett JB, Shah RV, Schoenike M, et al. Clinical and Hemodynamic Associations and Prognostic Implications of Ventilatory Efficiency in patients with preserved left ventricular systolic function. Circ Heart Fail. 2020;13(5):e006729.
doi: 10.1161/CIRCHEARTFAILURE.119.006729 pubmed: 32362167 pmcid: 7224335
Holverda S, Bogaard HJ, Groepenhoff H, Postmus PE, Boonstra A, Vonk-Noordegraaf A. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration. 2008;76(2):160–7.
doi: 10.1159/000110207 pubmed: 17960052
Torres-Castro R, Gimeno-Santos E, Vilaró J, Roqué-Figuls M, Moisés J, Vasconcello-Castillo L et al. Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis. Eur Respir Rev 2021, 30(160).
Hill K, Cavalheri V, Mathur S, Roig M, Janaudis-Ferreira T, Robles P, et al. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;5(5):Cd010821.
pubmed: 29845600
Pavitt MJ, Lewis A, Buttery SC, Fernandez BO, Mikus-Lelinska M, Banya WAS, et al. Dietary nitrate supplementation to enhance exercise capacity in hypoxic COPD: EDEN-OX, a double-blind, placebo-controlled, randomised cross-over study. Thorax. 2022;77(10):968–75.
doi: 10.1136/thoraxjnl-2021-217147 pubmed: 34853156

Auteurs

Hiromi Yanagi (H)

Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Keisuke Miki (K)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan. miki.keisuke.pu@mail.hosp.go.jp.

Kazumi Koyama (K)

Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Satoshi Miyamoto (S)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Yasuhiro Mihashi (Y)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Yuka Nagata (Y)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Kazuki Hashimoto (K)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Hisako Hashimoto (H)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Mari Fukai (M)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Tomonori Maekura (T)

Maekura Acupuncture Clinic, 6-13 Nyoidani, Minoh, Osaka, Japan.

Rika Yonezawa (R)

Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Shizuka Sakaguchi (S)

Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Takuro Nii (T)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Takanori Matsuki (T)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Kazuyuki Tsujino (K)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Hiroshi Kida (H)

Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH